Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ EMX2 Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA5117318
Description
Centrifuge briefly prior to opening.
This gene encodes a homeobox-containing transcription factor that is the homolog to the 'empty spiracles' gene in Drosophila. Research on this gene in humans has focused on its expression in three tissues: dorsal telencephalon, olfactory neuroepithelium, and urogenetial system. It is expressed in the dorsal telencephalon during development in a low rostral-lateral to high caudal-medial gradient and is proposed to pattern the neocortex into defined functional areas. It is also expressed in embryonic and adult olfactory neuroepithelia where it complexes with eukaryotic translation initiation factor 4E (eIF4E) and possibly regulates mRNA transport or translation. In the developing urogenital system, it is expressed in epithelial tissues and is negatively regulated by HOXA10. Alternative splicing results in multiple transcript variants encoding distinct proteins.
Specifications
EMX2 | |
Polyclonal | |
Unconjugated | |
EMX2 | |
empty spiracles homeobox 2; empty spiracles homolog 2; Empty spiracles-like protein 2; Emx2; Emx-2; Homeobox protein EMX2; Pdo; RGD1564797 | |
Rabbit | |
Antigen affinity chromatography | |
RUO | |
13797, 2018, 499380 | |
-20°C, Avoid Freeze/Thaw Cycles | |
Liquid |
Western Blot | |
2 mg/mL | |
PBS with 20% glycerol and 0.025% ProClin 300; pH 7 | |
Q04743, Q04744 | |
EMX2 | |
Carrier-protein conjugated synthetic peptide encompassing a sequence within the center region of Human EMX2. The exact sequence is proprietary. | |
100 μL | |
Primary | |
Human, Mouse, Rat | |
Antibody | |
IgG |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction